health pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? Retatrutide for weight loss: Study
Description
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, et al
75 DayJWOttawayNPattersonJTGelfanovVSmileyDGiddaJet al
24 Medications often used in IIH have been shown to exacerbate cognitive deficits in patients, with acetazolamide and topiramate impairing fluid intelligence
Several theories exist: The additive effects theory suggests that GIP and GLP-1 work through partially independent pathways
